Panjang
BOTHE end of the falling wedge
Hello All,
Fact News:
Phase 2B:
globenewswire.com/news-release/2021/01/12/2156714/0/en/Bone-Therapeutics-treats-first-patient-in-ALLOB-Phase-IIb-tibial-fracture-study.html
New partnership:
globenewswire.com/news-release/2021/01/14/2158343/0/en/Bone-Therapeutics-and-Rigenerand-sign-partnership-for-cell-therapy-process-development.html
Nice falling wedge on a weekly chart for Bone Therapeutics, and looks ready to breakout.
Also, the MA20 is ready to break up the MA50.
The falling wedge gives us a target @ 11,30€ around 290% from today's buying.
But for that, the chart needs to break 2 historic supports around 4.5€ and around 6.8€
Let's see if they are enough volume to strongly break this falling wedge!
Mathieu
Fact News:
Phase 2B:
globenewswire.com/news-release/2021/01/12/2156714/0/en/Bone-Therapeutics-treats-first-patient-in-ALLOB-Phase-IIb-tibial-fracture-study.html
New partnership:
globenewswire.com/news-release/2021/01/14/2158343/0/en/Bone-Therapeutics-and-Rigenerand-sign-partnership-for-cell-therapy-process-development.html
Nice falling wedge on a weekly chart for Bone Therapeutics, and looks ready to breakout.
Also, the MA20 is ready to break up the MA50.
The falling wedge gives us a target @ 11,30€ around 290% from today's buying.
But for that, the chart needs to break 2 historic supports around 4.5€ and around 6.8€
Let's see if they are enough volume to strongly break this falling wedge!
Mathieu
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.